Abstract
Medullary Thyroid cancer is a rare malignancy with aggressive behaviour, which can be either sporadic or hereditary. Diagnosis is based on measuring the serum calcitonin levels of patients with thyroid nodules or on screening for RET gene mutations of the first degree relatives of patients with hereditary MTC. Treatment is surgical and involves total thyroidectomy and central lymph node dissection in all diagnosed cases. Further lateral LN dissection should be performed when indicated and is further analyzed throughout the article. Postoperative observation includes biochemical markers of disease (calcitonin and CEA) as well as imaging studies when indicated. Recurrence rates are high because of early lymphatic metastases. However, the overall 5-year survival rates are also high.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lupone G, Antonino A, Rosato A, et al. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience. G Chir 2012;33:395–9.
Noullet S, Trésallet C, Godiris-Petit G, Hoang C, Leenhardt L, Menegaux F. Surgical management of sporadic medullary thyroid cancer. J Visc Surg 2011;148:244–249.
Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19:565–612.
Pacini F, Castagna M, Brilli L, Pentheroudakis G. Group ObotEGW. Thyroid cancer: ESMO Clinical Practice Guide-lines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v214–v9.
British Thyroid Association Guidelines for the management of thyroid cancer. 3rd Edition, 2014. http://www.britishthyroid-association.org/Guidelines (2007, 2014).
Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA. European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer. Eur Thyroid J 2012;1:5–14.
Tavares MR, Toledo SP, Montenegro FL, et al. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type II. Clinics (Sao Paulo) 2012;12:149–56.
Tamagnini P, Iacobone M, Sebag F, Marcy M, De Micco C, Henry JF. Lymph node involvement in macroscopic medullary thyroid carcinoma. Br J Surg 2005;92:449–53.
Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary thyroid cancer. Oncologist. 2008;13:539–47.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koutelidakis, I., Kapoulas, S., Papaziogas, V. et al. Surgical management of medullary thyroid cancer. Hellenic J Surg 87, 58–62 (2015). https://doi.org/10.1007/s13126-015-0181-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-015-0181-x